1. C-Reactive Protein, Interleukin-6, Trimethylamine-N-Oxide, Syndecan-1, Nitric Oxide, and Tumor Necrosis Factor Receptor-1 in Heart Failure with Preserved Versus Reduced Ejection Fraction: a Meta-Analysis

   • Xi Yao Gui
   • Simon W. Rabkin

   Clinical Heart Failure (T Meyer, Section Editor) 07 December 2022 Pages: 1 - 11

   

2. Remote Monitoring of Cardiac Implantable Electronic Devices: What is the Evidence?

   • Adrian Reinhardt
   • Rodolfo Ventura

   ReviewPaper 26 January 2023 Pages: 12 - 23

   

3. Heart Failure and Multimorbidity in Asia

   • Nathalie Ang
   • Chanchal Chandramouli
   • Jasper Tromp

   ReviewPaper Open access 22 February 2023 Pages: 24 - 32

   

4. What Is the Clinical Utility of Cardiac Troponins in Heart Failure? Are They Modifiable Beyond Their Prognostic Value?

   • David Agdashian
   • Lori B. Daniels

   ReviewPaper 31 January 2023 Pages: 33 - 43

5. Cardiotoxicity of Anti-Cancer Radiation Therapy: a Focus on Heart Failure

   • Alex Ritter
   • Cooper Quartermaine
   • Eric Miller

   ReviewPaper 24 January 2023 Pages: 44 - 55

   

6. Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies

   • Giacomo Tini
   • Giuliano Tocci
   • Paolo Spallarossa

   ReviewPaper Open access 25 January 2023 Pages: 56 - 62

   

7. Myocardial Metabolism in Heart Failure

   • Sher May Ng
   • Stefan Neubauer
   • Oliver J Rider

   ReviewPaper Open access 17 February 2023 Pages: 63 - 75

   

8. Cardiac Involvement in Mitochondrial Disorders

   • Tudor-Alexandru Popoiu
   • Jan Dudek
   • Edoardo Bertero

   ReviewPaper Open access 18 February 2023 Pages: 76 - 87

   

9. Spot Urinary Sodium Measurements: the Future Direction of the Treatment and Follow-up of Patients with Heart Failure

   • Evelyne Meekers
   • Wilfried Mullens

   ReviewPaper 21 February 2023 Pages: 88 - 100